The UK is launching a study to screen newborns for Spinal Muscular Atrophy (SMA), a deadly muscle condition, using heel prick blood samples.
Hundreds of thousands of babies will be screened as part of the new study. The process involves taking a small sample of blood from a newborn’s heel shortly after birth to detect the presence of SMA.
University of Oxford Study and National Screening Committee
Scientists at the University of Oxford are leading the research. The data gathered from these hundreds of thousands of screenings will serve as a critical evidence base for the UK National Screening Committee.
The committee will use the study’s findings to determine if SMA testing should move from a research phase to a permanent fixture in the national newborn screening program.
Jesy Nelson and the Campaign for Early Diagnosis
The shift toward systematic screening follows years of advocacy. Jesy Nelson, who has supported the cause, framed the development as a milestone for families who have historically struggled to get timely diagnoses.
“This is a victory for every family affected by SMA. Whilst it can’t change the future of our children, I know it marks the beginning of a brighter future for future SMA families.”
Jesy Nelson, via BBC
Nelson noted that the prospect of early diagnosis provides a day of hope
and the possibility of the best possible outcomes for infants born with the condition.
James Murray on Treatment Windows
Health Secretary James Murray stated he was in awe
of the campaigners who pushed for increased awareness of the condition.
Murray emphasized the human cost of delayed diagnosis, noting that no parent should have to witness their child lose the ability to breathe or move when earlier treatment could have altered the trajectory of the disease.
For more information on the specifics of SMA and newborn screening, please consult your healthcare provider.
Find more reporting in our Health section.